Cargando…
Bone tumor-homing nanotherapeutics for prolonged retention in tumor microenvironment and facilitated apoptotic process via mevalonate pathway inhibition
Bone malignancy features a mineralized extracellular matrix primarily composed of hydroxyapatite, which interferes with the distribution and activity of antineoplastic agents. Herein, we report bone tumor-homing polymeric nanotherapeutics consisting of alendronate-decorated chondroitin sulfate A-gra...
Autores principales: | Kang, Nae-Won, Visetvichaporn, Voradanu, Nguyen, Duy-Thuc, Shin, Eun Kyung, Kim, Dahan, Kim, Min-Jae, Yoo, So-Yeol, Lee, Jae-Young, Kim, Dae-Duk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978036/ https://www.ncbi.nlm.nih.gov/pubmed/36873733 http://dx.doi.org/10.1016/j.mtbio.2023.100591 |
Ejemplares similares
-
Mutant p53, the Mevalonate Pathway and the Tumor Microenvironment Regulate Tumor Response to Statin Therapy
por: Pereira, Madison, et al.
Publicado: (2022) -
Celecoxib normalizes the tumor microenvironment and enhances small nanotherapeutics delivery to A549 tumors in nude mice
por: Zhang, Bo, et al.
Publicado: (2017) -
Leukocyte-mediated Delivery of Nanotherapeutics in Inflammatory and Tumor Sites
por: Dong, Xinyue, et al.
Publicado: (2017) -
Progress in advanced nanotherapeutics for enhanced photodynamic immunotherapy of tumor
por: Wei, Xiao, et al.
Publicado: (2022) -
The mevalonate pathway promotes the metastasis of osteosarcoma by regulating YAP1 activity via RhoA
por: Du, Xing, et al.
Publicado: (2020)